Reaction Biology Announces Integrated Drug Discovery Solutions: The Reaction Oncology Platform
MALVERN, PA, FREIBURG, Germany, HAIMEN, China and NIJMEGEN, the Netherlands, February 02, 2022 / B3C newswire / -- Reaction Biology, a solution provider for discovering small molecules for 20 years, has created a comprehensive platform for integrated drug discovery comprising target research, hit identification, hit...